Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：416
作者：
Frueh, M. [1 ]
De Ruysscher, D. [2 ]
Popat, S. [3 ]
Crino, L. [4 ]
Peters, S. [5 ]
Felip, E. [6 ]
机构：
[1] Kantonsspital St Gallen, Dept Med Oncol & Hematol, St Gallen, Switzerland
[2] Katholieke Univ Leuven, Univ Hosp Leuven, Louvain, Belgium
[3] Royal Marsden Hosp, London SW3 6JJ, England
[4] Hosp Santa Maria Misericordia, Dept Oncol, Perugia, Italy
[5] CHU Vaudois, Dept Oncol, Lausanne, Switzerland
[6] Vall dHebron Univ Hosp, Med Oncol Serv, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
PROPHYLACTIC CRANIAL IRRADIATION; PHASE-III TRIAL; QUALITY-OF-LIFE; RADIATION-THERAPY; THORACIC RADIOTHERAPY; 1ST-LINE TREATMENT; 7TH EDITION; RTOG; 0212; STAGE-I; CHEMOTHERAPY;
D O I：
10.1093/annonc/mdt178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：99 / 105
页数：7
相关论文
共 43 条
  • [1] Blackstock A William, 2005, Clin Lung Cancer, V6, P287, DOI 10.3816/CLC.2005.n.007
  • [2] Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published randomized controlled trials
    Bozcuk, H
    Artac, M
    Ozdogan, M
    Savas, B
    [J]. CANCER, 2005, 104 (12) : 2650 - 2657
  • [3] Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers
    Cuffe, Sinead
    Moua, Teng
    Summerfield, Ruth
    Roberts, Heidi
    Jett, James
    Shepherd, Frances A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (04) : 818 - 822
  • [4] Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
    De Ruysscher, D
    Pijls-Johannesma, M
    Bentzen, SM
    Minken, A
    Wanders, R
    Lutgens, L
    Hochstenbag, M
    Boersma, L
    Wouters, B
    Lammering, G
    Vansteenkiste, J
    Lambin, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) : 1057 - 1063
  • [5] Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer
    Eckardt, John R.
    von Pawel, Joachim
    Pujol, Jean-Louis
    Papai, Zsolt
    Quoix, Elisabeth
    Ardizzoni, Andrea
    Poulin, Ruth
    Preston, Alaknanda J.
    Dane, Graham
    Ross, Graham
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) : 2086 - 2092
  • [6] Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer
    Eckardt, JR
    von Pawel, J
    Papai, Z
    Tomova, A
    Tzekova, V
    Crofts, TE
    Brannon, S
    Wissel, P
    Ross, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) : 2044 - 2051
  • [7] Topotecan/Cisplatin Compared with Cisplatin/Etoposide as First-Line Treatment for Patients with Extensive Disease Small-Cell Lung Cancer Final Results of a Randomized Phase III Trial
    Fink, Thomas H.
    Huber, Rudolf M.
    Heigener, David F.
    Eschbach, Corrina
    Waller, Cornelius
    Steinhauer, Ernst U.
    Virchow, Johann C.
    Eberhardt, Frank
    Schweisfurth, Hans
    Schroeder, Michael
    Ittel, Thomas
    Hummler, Simone
    Banik, Norbert
    Bogenrieder, Thomas
    Acker, Thomas
    Wolf, Martin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : 1432 - 1439
  • [8] Tumor Response and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Extensive Stage Small-Cell Lung Cancer Findings on the Basis of North Central Cancer Treatment Group Trials
    Foster, Nathan R.
    Qi, Yingwei
    Shi, Qian
    Krook, James E.
    Kugler, John W.
    Jett, James R.
    Molina, Julian R.
    Schild, Steven E.
    Adjei, Alex A.
    Mandrekar, Sumithra J.
    [J]. CANCER, 2011, 117 (06) : 1262 - 1271
  • [9] Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer
    Fried, DB
    Morris, DE
    Poole, C
    Rosenman, JG
    Halle, JS
    Detterbeck, FC
    Hensing, TA
    Socinski, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) : 4837 - 4845
  • [10] Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database
    Govindan, Ramaswamy
    Page, Nathan
    Morgensztern, Daniel
    Read, William
    Tierney, Ryan
    Vlahiotis, Anna
    Spitznagel, Edward L.
    Piccirillo, Jay
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) : 4539 - 4544
12345